Terms: = Gastric cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
4 results:
1. Trends in Survival of Patients with Primary gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database.
Liu PP; Xia Y; Bi XW; Wang Y; Sun P; Yang H; Li ZM; Jiang WQ
Dis Markers; 2018; 2018():7473935. PubMed ID: 30410635
[TBL] [Abstract] [Full Text] [Related]
2. CD33⁺/p-STAT1⁺ double-positive cell as a prognostic factor for stage IIIa gastric cancer.
Dong J; Li J; Liu SM; Feng XY; Chen S; Chen YB; Zhang XS
Med Oncol; 2013 Mar; 30(1):442. PubMed ID: 23307253
[TBL] [Abstract] [Full Text] [Related]
3. Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance.
Levidou G; Korkolopoulou P; Nikiteas N; Tzanakis N; Thymara I; Saetta AA; Tsigris C; Rallis G; Vlasis K; Patsouris E
Virchows Arch; 2007 May; 450(5):519-27. PubMed ID: 17429689
[TBL] [Abstract] [Full Text] [Related]
4. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
[TBL] [Abstract] [Full Text] [Related]
